Paper8523006
Use of antibiotic-impregnated cement during hip and knee arthroplasty in the United States.
Heck D and 4 others. J Arthroplasty, 1995. Cited by 70 papers, by iCite.
Cite this record
ConductScience Library. Use of antibiotic-impregnated cement during hip and knee arthroplasty in the United States. Papers, record 8523006. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8523006
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Use of antibiotic-impregnated cement during hip and knee arthroplasty in the United States.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Antibiotic Prophylaxis | Major topic |
| Bone Cements | Major topic |
| Drug Delivery Systems | Major topic |
| Hip Prosthesis | Major topic |
| Knee Prosthesis | Major topic |
| Drug Utilization | |
| Humans | |
| Practice Patterns, Physicians' | |
| Prosthesis-Related Infections |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39590051 | Vancomycin-Loaded Silk Fibroin/Calcium Phosphate/Methylcellulose-Based In Situ Thermosensitive Hydrogel: A Potential Function for Bone Regeneration. | Gels | 2024 | https://conductscience.org/library/papers/39590051 | PubMed |
| 39443495 | Application of a metatranscriptomics technology, CSI-Dx, for the detection of pathogens associated with prosthetic joint infections. | Sci Rep | 2024 | https://conductscience.org/library/papers/39443495 | PubMed |
| 32904007 | The Impact of Antibiotic-Loaded Bone Cement on Antibiotic Resistance in Periprosthetic Knee Infections. | Clin Orthop Surg | 2020 | https://conductscience.org/library/papers/32904007 | PubMed |
| 29312854 | Antibiotic bone cement's effect on infection rates in primary and revision total knee arthroplasties. | World J Orthop | 2017 | https://conductscience.org/library/papers/29312854 | PubMed |
| 27488378 | What is the Intraarticular Concentration of Tobramycin Using Low-dose Tobramycin Bone Cement in TKA: An In Vivo Analysis? | Clin Orthop Relat Res | 2016 | https://conductscience.org/library/papers/27488378 | PubMed |
| 26716084 | Use of antibiotic-loaded cement in total knee arthroplasty. | World J Orthop | 2015 | https://conductscience.org/library/papers/26716084 | PubMed |
| 20191335 | Inhibition of Staphylococcus epidermidis biofilms using polymerizable vancomycin derivatives. | Clin Orthop Relat Res | 2010 | https://conductscience.org/library/papers/20191335 | PubMed |
| 19838348 | Prophylactic use of antibiotic-loaded bone cement in primary total knee arthroplasty: Justified or not? | Indian J Orthop | 2009 | https://conductscience.org/library/papers/19838348 | PubMed |
| 19259789 | A preliminary study of the release of quaternary ammonium antimicrobial compounds from acrylic bone cement. | J Mater Sci Mater Med | 2009 | https://conductscience.org/library/papers/19259789 | PubMed |
| 10202904 | Antibiotic resistance--to treat... | Nat Med | 1999 | https://conductscience.org/library/papers/10202904 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8523006
GET https://conductscience.org/api/papers/v1/8523006/authors